Document is current
Any future updates will be listed below
-
Authors
Naganuma, Makoto https://orcid.org/0000-0002-4244-3243
Shiga, Hisashi
Shimoda, Masayuki
Matsuura, Minoru
Takenaka, Kento
Fujii, Toshimitsu
Yamamoto, Shojiro
Matsubayashi, Mao
Kobayashi, Taku
Aoyama, Nobuo
Saito, Daisuke
Yokoyama, Kaoru
Moriya, Kei
Tsuchiya, Kiichiro
Shibui, Shunsuke
Kawamoto, Ami
Shimizu, Hiromichi
Okamoto, Ryuichi
Sakamoto, Kazuki
Yaguchi, Katsuki
Kunisaki, Reiko
Akiyama, Shintaro
Hayashi, Ryohei
Hasui, Keisuke
Kanmura, Shuji
Bamba, Shigeki
Mishima, Yoshiyuki
Kakimoto, Kazuki
Sugimoto, Shinya
Nakazawa, Atsushi
Abe, Takayuki
Ogata, Haruhiko
Hisamatsu, Tadakazu
,
Fukata, Norimasa
Saito, Eiko
Nagahori, Masakazu
Otsuka, Kazuo
Betto, Tomohiro
Kobayashi, Kiyonori
Takasago, Kakeshi
Oka, Shiro
Tanaka, Shinji
Sakuraba, Hirotake
Andoh, Akira
Ishihara, Shunji
Miyazaki, Takako
Nakamura, Shiro
Kiyohara, Hiroki
Sujino, Tomohisa
Mikami, Yohei
Kanai, Takanori
Shiotani, Akiko
Handa, Osamu
Nanjyo, Sohachi
Takashima, Yusuke
Sasaki, Makoto
Ueno, Nobuhiro
Fujiya, Mikihiro
Takagi, Tomohisa
Uchiyama, Kazuhiko
Wagatsuma, Kohei
Nakase, Hiroshi
Omori, Teppei
Matsuoka, Katsuyoshi
-
Funding
Funding for this research was provided by:
the Japan Agency for Medical Research and Development (JP20ek0109463)
Ministry of Health, Labour and Welfare
- License Information
-
More Information
Article History
Received: 21 November 2024
Accepted: 11 January 2025
First Online: 30 January 2025
Declarations
:
: Makoto Naganuma received grants from AbbVie GK, Alfresa Pharma Corporation, Kyorin Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd. Mitsubishi-Tanabe Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co. Ltd., and lecture fees from EA Pharma Co., Ltd, Gilead Science Inc, Takeda Pharmacal Co., Ltd. AbbVie GK, Janssen Pharmaceutical K.K., Mitsubishi-Tanabe Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd. and Pfizer Co., Ltd, outside the submitted work. Hisashi Shiga received lecture fees from Mitsubishi Tanabe Pharma Corp., AbbVie Inc., EA Pharma Co. Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Gilead Sciences Inc and Mochida Pharmaceutical Co. Ltd., outside the submitted work. Minoru Matsuura received lecture fees from Jansen Pharmaceutical K.K. and AbbVie GK., outside the submitted work. Toshimitsu Fujii received grants from AbbVie, Alfresa, Boehringer Ingelheim, BristolMyers Squibb, Celgene, Celltrion, Janssen, Kissei, Mebix, Sanofi, EA Pharma., Eli Lilly, Gilead Sciences, and Takeda. lecture fees from Abbie, Janssen, Mitsubishi-Tanabe and Takeda, outside the submitted work. Taku Kobayashi served as an advisory board member, consultant, or speaker for AbbVie, Alfresa Pharma, Alimentiv, Bristol Myers Squibb, Celltrion, Covidien, EA Pharma, Eli Lilly, Ferring Pharmaceuticals, Galapagos, Gilead Sciences, Janssen Pharmaceuticals, JIMRO, Kissei Pharmaceutical, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Nippon Kayaku, Pfizer, Takeda, and Zeria Pharmaceutical, and has received research funding from AbbVie, Alfresa Pharma, Bristol Myers Squibb, EA Pharma, Gilead Sciences, Kyorin Pharmaceutical, Mochida Pharmaceutical, Nippon Kayaku, Otsuka Holdings, Pfizer, Sekisui Medical, Samsung, Takeda, and Zeria Pharmaceutical., outside the submitted work. Kaoru Yokoyama received lecture frees from EA Pharma Co., Ltd. and AbbVie GK, outside the submitted work. Kiichiro Tsuchiya received grants from Eli Lilly and Kyowa Kirin Co,. Ltd. and lecture fees from Takeda Pharmaceutical Company Limited, Abbie Inc, EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., outside the submitted work. Ryuichi Okamoto received grants from EA Pharma Co., Ltd. Medical & Biological Laboratories Co., Ltd and Mochida Pharmaceutical Co., Ltd.., outside the submitted work. Shintaro Akiyama received lecture frees from EA Pharma Co., Ltd. and AbbVie GK outside the submitted work. Tadakazu Hisamatsu received research grants from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, JIMRO Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., and Mochida Pharmaceutical Co., Ltd. and received lecture fees from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, Celgene K.K., EA Pharma Co., Ltd., Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Kissei pharmaceutical Co., LTD., Nichi-Iko Co., LTD., Gilead Sciences, Inc., and Pfizer Inc. Other authors do not have any Conflict of Interests.
: The datasets generated and/or analyzed during the study are not publicly available because we did not receive permission for them to be accessible to researchers from outside organizations. However, they will be available from the corresponding author upon reasonable request after obtaining permission from the Ethics Committee of Kansai Medical University.
